- Home
- PMN vs ENLV Comparison
PMN vs ENLV Comparison
Compare PMN & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PMN | ENLV |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.5M | 26.6M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | PMN | ENLV |
|---|---|---|
| Price | $8.92 | $0.87 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $72.67 | $7.00 |
| AVG Volume (30 Days) | 43.4K | ★ 11.5M |
| Earning Date | 11-12-2025 | 11-28-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.27 | $0.83 |
| 52 Week High | $39.75 | $2.10 |
Technical Indicators
Market Signals| Indicator | PMN | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 87.30 | 39.28 |
| Support Level | $7.35 | $0.89 |
| Resistance Level | $9.26 | $1.25 |
| Average True Range (ATR) | 0.64 | 0.11 |
| MACD | 0.34 | -0.01 |
| Stochastic Oscillator | 95.98 | 5.06 |
Price Performance
Historical ComparisonAbout PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.